APO Research
Talk to an analyst

APO RESEARCH · REPORT

Parecoxib Sodium

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Parecoxib Sodium Market Outlook and Growth Opportunities 2026

22 December 2025190 pages

Choose your research edition.

Industry ResearchParecoxib Sodium Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Parecoxib Sodium Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Parecoxib Sodium Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Parecoxib Sodium Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Parecoxib Sodium Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Parecoxib Sodium market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Parecoxib Sodium is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Parecoxib Sodium market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Parecoxib Sodium market include Sailong Pharma, Chiarai Tianqing, Qilu Pharma, Kelun Pharma and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Parecoxib Sodium market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Parecoxib Sodium and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Parecoxib Sodium sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Parecoxib Sodium market size, projected growth trends, production technologies, key applications, and end-use industries.

Parecoxib Sodium Segment by Company

Sailong Pharma

Chiarai Tianqing

Qilu Pharma

Kelun Pharma

Pfizer

Parecoxib Sodium Segment by Type

Original Drug

Generic Drug

Parecoxib Sodium Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Parecoxib Sodium Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Parecoxib Sodium status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Parecoxib Sodium market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Parecoxib Sodium significant trends, drivers, influence factors in global and regions.

6. To analyze Parecoxib Sodium competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parecoxib Sodium market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Parecoxib Sodium and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parecoxib Sodium.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Parecoxib Sodium market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Parecoxib Sodium industry.

Chapter 3: Detailed analysis of Parecoxib Sodium manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Parecoxib Sodium in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Parecoxib Sodium in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Parecoxib Sodium Industry Trends Table 2. Parecoxib Sodium Industry Drivers Table 3. Parecoxib Sodium Industry Opportunities and Challenges Table 4. Parecoxib Sodium Industry Restraints Table 5. Global Parecoxib Sodium Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Parecoxib Sodium Revenue Share by Company (2021-2026) Table 7. Global Parecoxib Sodium Sales Volume by Company (kg) & (2021-2026) Table 8. Global Parecoxib Sodium Sales Volume Share by Company (2021-2026) Table 9. Global Parecoxib Sodium Average Price (US$/kg) of Company (2021-2026) Table 10. Global Parecoxib Sodium Company Ranking, (2024-2026) & (USD Million) Table 11. Global Parecoxib Sodium Key Company Manufacturing Base & Headquarters Table 12. Global Parecoxib Sodium Company, Product Type & Application Table 13. Global Parecoxib Sodium Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Parecoxib Sodium by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Parecoxib Sodium Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 20. Global Parecoxib Sodium Sales Volume by Type (2021-2026) & (kg) Table 21. Global Parecoxib Sodium Sales Volume by Type (2027-2032) & (kg) Table 22. Global Parecoxib Sodium Sales Volume Share by Type (2021-2026) Table 23. Global Parecoxib Sodium Sales Volume Share by Type (2027-2032) Table 24. Global Parecoxib Sodium Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Parecoxib Sodium Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Parecoxib Sodium Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Parecoxib Sodium Sales Value Share by Type (2021-2026) Table 28. Global Parecoxib Sodium Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Online Pharmacies Table 31. Significant Companies of Retail Pharmacies Table 32. Global Parecoxib Sodium Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Parecoxib Sodium Sales Volume by Application (2021-2026) & (kg) Table 34. Global Parecoxib Sodium Sales Volume by Application (2027-2032) & (kg) Table 35. Global Parecoxib Sodium Sales Volume Share by Application (2021-2026) Table 36. Global Parecoxib Sodium Sales Volume Share by Application (2027-2032) Table 37. Global Parecoxib Sodium Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Parecoxib Sodium Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Parecoxib Sodium Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Parecoxib Sodium Sales Value Share by Application (2021-2026) Table 41. Global Parecoxib Sodium Sales Value Share by Application (2027-2032) Table 42. Global Parecoxib Sodium Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Parecoxib Sodium Sales by Region (2021-2026) & (kg) Table 44. Global Parecoxib Sodium Sales Market Share by Region (2021-2026) Table 45. Global Parecoxib Sodium Sales by Region (2027-2032) & (kg) Table 46. Global Parecoxib Sodium Sales Market Share by Region (2027-2032) Table 47. Global Parecoxib Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Parecoxib Sodium Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Parecoxib Sodium Sales Value Share by Region (2021-2026) Table 50. Global Parecoxib Sodium Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Parecoxib Sodium Sales Value Share by Region (2027-2032) Table 52. Global Parecoxib Sodium Market Average Price (US$/kg) by Region (2021-2026) Table 53. Global Parecoxib Sodium Market Average Price (US$/kg) by Region (2027-2032) Table 54. Global Parecoxib Sodium Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Parecoxib Sodium Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Parecoxib Sodium Sales by Country (2021-2026) & (kg) Table 57. Global Parecoxib Sodium Sales Market Share by Country (2021-2026) Table 58. Global Parecoxib Sodium Sales by Country (2027-2032) & (kg) Table 59. Global Parecoxib Sodium Sales Market Share by Country (2027-2032) Table 60. Global Parecoxib Sodium Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Parecoxib Sodium Sales Value Market Share by Country (2021-2026) Table 62. Global Parecoxib Sodium Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Parecoxib Sodium Sales Value Market Share by Country (2027-2032) Table 64. Sailong Pharma Company Information Table 65. Sailong Pharma Business Overview Table 66. Sailong Pharma Parecoxib Sodium Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 67. Sailong Pharma Parecoxib Sodium Product Portfolio Table 68. Sailong Pharma Recent Development Table 69. Chiarai Tianqing Company Information Table 70. Chiarai Tianqing Business Overview Table 71. Chiarai Tianqing Parecoxib Sodium Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 72. Chiarai Tianqing Parecoxib Sodium Product Portfolio Table 73. Chiarai Tianqing Recent Development Table 74. Qilu Pharma Company Information Table 75. Qilu Pharma Business Overview Table 76. Qilu Pharma Parecoxib Sodium Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 77. Qilu Pharma Parecoxib Sodium Product Portfolio Table 78. Qilu Pharma Recent Development Table 79. Kelun Pharma Company Information Table 80. Kelun Pharma Business Overview Table 81. Kelun Pharma Parecoxib Sodium Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 82. Kelun Pharma Parecoxib Sodium Product Portfolio Table 83. Kelun Pharma Recent Development Table 84. Pfizer Company Information Table 85. Pfizer Business Overview Table 86. Pfizer Parecoxib Sodium Sales (kg), Value (US$ Million), Price (US$/kg) and Gross Margin (2021-2026) Table 87. Pfizer Parecoxib Sodium Product Portfolio Table 88. Pfizer Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Parecoxib Sodium Distributors List Table 92. Parecoxib Sodium Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Parecoxib Sodium Product Image Figure 2. Global Parecoxib Sodium Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 4. Global Parecoxib Sodium Sales (2021-2032) & (kg) Figure 5. Global Parecoxib Sodium Sales Average Price (US$/kg) & (2021-2032) Figure 6. Global Parecoxib Sodium Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Parecoxib Sodium Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 12. Global Parecoxib Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Parecoxib Sodium Sales Volume Share by Type (2021-2032) Figure 14. Global Parecoxib Sodium Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Parecoxib Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Parecoxib Sodium Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacies Image Figure 18. Online Pharmacies Image Figure 19. Retail Pharmacies Image Figure 20. Global Parecoxib Sodium Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Parecoxib Sodium Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Parecoxib Sodium Sales Volume Share by Application (2021-2032) Figure 23. Global Parecoxib Sodium Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Parecoxib Sodium Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Parecoxib Sodium Sales Value Share by Application (2021-2032) Figure 26. Global Parecoxib Sodium Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Parecoxib Sodium Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Parecoxib Sodium Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Parecoxib Sodium Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 31. North America Parecoxib Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Parecoxib Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Parecoxib Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 37. South America Parecoxib Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Parecoxib Sodium Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Parecoxib Sodium Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Parecoxib Sodium Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Parecoxib Sodium Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Parecoxib Sodium Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Sailong Pharma
  • Chiarai Tianqing
  • Qilu Pharma
  • Kelun Pharma
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Parecoxib Sodium Sales Value (2021-2032)
  4. 1.2.2 Global Parecoxib Sodium Sales Volume (2021-2032)
  5. 1.2.3 Global Parecoxib Sodium Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Parecoxib Sodium Market Dynamics
  1. 2.1 Parecoxib Sodium Industry Trends
  2. 2.2 Parecoxib Sodium Industry Drivers
  3. 2.3 Parecoxib Sodium Industry Opportunities and Challenges
  4. 2.4 Parecoxib Sodium Industry Restraints
3 Parecoxib Sodium Market by Company
  1. 3.1 Global Parecoxib Sodium Company Revenue Ranking in 2025
  2. 3.2 Global Parecoxib Sodium Revenue by Company (2021-2026)
  3. 3.3 Global Parecoxib Sodium Sales Volume by Company (2021-2026)
  4. 3.4 Global Parecoxib Sodium Average Price by Company (2021-2026)
  5. 3.5 Global Parecoxib Sodium Company Ranking (2024-2026)
  6. 3.6 Global Parecoxib Sodium Company Manufacturing Base and Headquarters
  7. 3.7 Global Parecoxib Sodium Company Product Type and Application
  8. 3.8 Global Parecoxib Sodium Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Parecoxib Sodium Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Parecoxib Sodium Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Parecoxib Sodium Market by Type
  1. 4.1 Parecoxib Sodium Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Parecoxib Sodium Sales Volume by Type
  5. 4.2.1 Global Parecoxib Sodium Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Parecoxib Sodium Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Parecoxib Sodium Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Parecoxib Sodium Sales Value by Type
  9. 4.3.1 Global Parecoxib Sodium Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Parecoxib Sodium Sales Value by Type (2021-2032)
  11. 4.3.3 Global Parecoxib Sodium Sales Value Share by Type (2021-2032)
5 Parecoxib Sodium Market by Application
  1. 5.1 Parecoxib Sodium Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Parecoxib Sodium Sales Volume by Application
  6. 5.2.1 Global Parecoxib Sodium Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Parecoxib Sodium Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Parecoxib Sodium Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Parecoxib Sodium Sales Value by Application
  10. 5.3.1 Global Parecoxib Sodium Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Parecoxib Sodium Sales Value by Application (2021-2032)
  12. 5.3.3 Global Parecoxib Sodium Sales Value Share by Application (2021-2032)
6 Parecoxib Sodium Regional Sales and Value Analysis
  1. 6.1 Global Parecoxib Sodium Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Parecoxib Sodium Sales by Region (2021-2032)
  3. 6.2.1 Global Parecoxib Sodium Sales by Region: 2021-2026
  4. 6.2.2 Global Parecoxib Sodium Sales by Region (2027-2032)
  5. 6.3 Global Parecoxib Sodium Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Parecoxib Sodium Sales Value by Region (2021-2032)
  7. 6.4.1 Global Parecoxib Sodium Sales Value by Region: 2021-2026
  8. 6.4.2 Global Parecoxib Sodium Sales Value by Region (2027-2032)
  9. 6.5 Global Parecoxib Sodium Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Parecoxib Sodium Sales Value (2021-2032)
  12. 6.6.2 North America Parecoxib Sodium Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Parecoxib Sodium Sales Value (2021-2032)
  15. 6.7.2 Europe Parecoxib Sodium Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Parecoxib Sodium Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Parecoxib Sodium Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Parecoxib Sodium Sales Value (2021-2032)
  21. 6.9.2 South America Parecoxib Sodium Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Parecoxib Sodium Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Parecoxib Sodium Sales Value Share by Country, 2025 VS 2032
7 Parecoxib Sodium Country-level Sales and Value Analysis
  1. 7.1 Global Parecoxib Sodium Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Parecoxib Sodium Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Parecoxib Sodium Sales by Country (2021-2032)
  4. 7.3.1 Global Parecoxib Sodium Sales by Country (2021-2026)
  5. 7.3.2 Global Parecoxib Sodium Sales by Country (2027-2032)
  6. 7.4 Global Parecoxib Sodium Sales Value by Country (2021-2032)
  7. 7.4.1 Global Parecoxib Sodium Sales Value by Country (2021-2026)
  8. 7.4.2 Global Parecoxib Sodium Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Parecoxib Sodium Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Parecoxib Sodium Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Parecoxib Sodium Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sailong Pharma
  2. 8.1.1 Sailong Pharma Company Information
  3. 8.1.2 Sailong Pharma Business Overview
  4. 8.1.3 Sailong Pharma Parecoxib Sodium Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sailong Pharma Parecoxib Sodium Product Portfolio
  6. 8.1.5 Sailong Pharma Recent Developments
  7. 8.2 Chiarai Tianqing
  8. 8.2.1 Chiarai Tianqing Company Information
  9. 8.2.2 Chiarai Tianqing Business Overview
  10. 8.2.3 Chiarai Tianqing Parecoxib Sodium Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chiarai Tianqing Parecoxib Sodium Product Portfolio
  12. 8.2.5 Chiarai Tianqing Recent Developments
  13. 8.3 Qilu Pharma
  14. 8.3.1 Qilu Pharma Company Information
  15. 8.3.2 Qilu Pharma Business Overview
  16. 8.3.3 Qilu Pharma Parecoxib Sodium Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Qilu Pharma Parecoxib Sodium Product Portfolio
  18. 8.3.5 Qilu Pharma Recent Developments
  19. 8.4 Kelun Pharma
  20. 8.4.1 Kelun Pharma Company Information
  21. 8.4.2 Kelun Pharma Business Overview
  22. 8.4.3 Kelun Pharma Parecoxib Sodium Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Kelun Pharma Parecoxib Sodium Product Portfolio
  24. 8.4.5 Kelun Pharma Recent Developments
  25. 8.5 Pfizer
  26. 8.5.1 Pfizer Company Information
  27. 8.5.2 Pfizer Business Overview
  28. 8.5.3 Pfizer Parecoxib Sodium Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Pfizer Parecoxib Sodium Product Portfolio
  30. 8.5.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Parecoxib Sodium Value Chain Analysis
  2. 9.1.1 Parecoxib Sodium Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Parecoxib Sodium Sales Mode & Process
  6. 9.2 Parecoxib Sodium Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Parecoxib Sodium Distributors
  9. 9.2.3 Parecoxib Sodium Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst